Healthcare companies are not completely immune to an economic downturn. Nonetheless, they usually tend to fare better than stocks in other sectors. Generally, people cut down their spending on discretionary items considerably during a recession, while they don’t reduce their healthcare expenditure to that extent. With that thought in mind, we used TipRanks’ Stock Comparison Tool to place Pfizer (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), and CVS Health (NYSE:CVS) against each other and pick the most attractive healthcare stock.   Pfizer (PFE) Stock Pfizer’s third-quarter revenue declined year-over-year due to lower demand for its COVID-19 vaccine Comirnaty (developed in partnership with BioNTech (BNTX)).
https://www.tipranks.com/news/article/pfe-jnj-or-cvs-which-healthcare-stock-is-a-strong-buy-for-wall-street-pros?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 1 2023 まで 2 2023 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 2 2022 まで 2 2023 Pfizerのチャートをもっと見るにはこちらをクリック